Buy this biotech stock on pivot to immune disease treatments, Wells Fargo says
- Posted on April 20, 2026
- By CNBC
- 0 Views
- 1 min read
Buy this biotech stock on pivot to immune disease treatments, Wells Fargo says

The bank's research arm raised its rating on the stock to overweight from equal weight.